Cite
HARVARD Citation
Nawata, M. et al. (2016). Clinically relevant radiographic progression in joint destruction in RA patients with abnormal MMP-3 or high levels of CRP despite 1-year treatment with infliximab. Modern rheumatology. 26 (6), pp. 807-812. [Online].